Advances in Diagnosis and Therapies of Ocular Diseases
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 10 July 2025 | Viewed by 22
Special Issue Editor
Interests: diabetic retinopathy; glaucoma; age related macular degeneration; optic neuropathies, inflammatory biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite continuous improvements in diagnosis and therapy, blindness and visual impairment are still significant challenges in healthcare systems, in the context of increasing population and aging globally. Cataract, glaucoma, age-related macular degeneration, and uncorrected refraction errors are listed among the top causes of visual impairment worldwide. In recent years, there have been significant achievements regarding ophthalmic imaging and development of surgical techniques and devices. In the era of artificial intelligence and telemedicine, new techniques were designed to improve screening and monitoring of chronic ophthalmic diseases.
In this Special Issue, we would like to invite you to submit papers (original research and reviews) thematically connected to the scope of this Special Issue. We are particularly, but not exclusively, interested in papers focused on the recent development in diagnosis and therapy of ophthalmic diseases, management of postoperative complications, new biomarkers of diagnosis and monitoring, the impact of COVID-19 pandemic on the ocular diseases, and the use of artificial intelligence-based models in ophthalmology.
Dr. Ana Maria Dascalu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- early biomarkers
- retinal and optic nerve imaging
- ocular surgery
- glaucoma drainage devices
- neuroprotection
- refraction errors
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
